Eric Pauwels, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 5,334 shares at $44.50 ($240K) on 2025-01-08, disclosed to the SEC on 2025-01-10.
Scheduled sale ($240k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.34 | 1,599 | $72K | 30.2% |
| 2 | $45.34 | 1,599 | $72K | 30.2% |
| 3 | $44.50 | 2,136 | $95K | 39.6% |
| Total | $45.00 avg | 5,334 | $240K | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |